The Claim
Phentermine/topiramate and naltrexone/bupropion are associated with increased rates of all adverse events in adults with essential hypertension compared to placebo, with risk ratios of 1.13 and 1.69 respectively, while orlistat is not associated with a clear change in overall adverse events.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with essential hypertension, phentermine/topiramate and naltrexone/bupropion are linked to higher rates of adverse events compared to placebo, with risk ratios of 1.13 and 1.69, while orlistat shows no clear difference in adverse event rates.
See the scientific wording
Phentermine/topiramate and naltrexone/bupropion are associated with a probable increase in all adverse events in adults with essential hypertension compared to placebo, with risk ratios of 1.13 and 1.69 respectively, based on moderate-certainty evidence from single large randomized trials, while orlistat shows no clear effect on overall adverse events with very low certainty.
These drugs alter brain chemicals that control appetite, which also affect how the body manages stress and automatic functions like heart rate and blood pressure. This causes the body to react more strongly to normal signals, leading to more physical side effects.
What the research says
1 studyStudy: Long-term effects of weight-reducing drugs in people with hypertension.
In people with high blood pressure, two weight-loss drugs (phentermine/topiramate and naltrexone/bupropion) were found to cause more side effects than a placebo, and the study is pretty sure about this. Orlistat didn’t clearly cause more side effects, and the study wasn’t sure either.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.